Editorial
Physician-scientists through ongoing research strive to improve our understanding of how perioperative risk assessment and management techniques could contribute to improved outcomes after surgery. Every year a substantial number of studies are published, and it often can be incredibly challenging for practicing clinicians to remain up-to-date on the current perioperative risk assessment and management techniques of surgical patients. This is why Seminars in Cardiothoracic and Vascular Anesthesia has always devoted an issue in March to providing a spectrum of articles revolving around the topics of cardiac anesthesia, cardiothoracic surgery, cardiac critical care medicine, congenital cardiac anesthesia, and more recently of abdominal and thoracic transplant anesthesia. These so called "Noteworthy" series have now entered into their fifth year, and the series continues to evolve as each author group has used their own approach for selecting relevant publications from their respective fields. In the end, our Noteworthy series have always provided an excellent summary of contemporary studies spanning across multiple disciplines that have assisted our readership in focusing on topics relevant to their respective clinical areas of expertise.
Our annual review of the relevant literature begins with 3 articles that focused on adult cardiac care shared between cardiac anesthesiology, cardiac surgery, and echocardiography. The leading article on the topic of Cardiothoracic Anesthesiology is focused on large scale clinical studies devoted to patient-oriented outcome research of various perioperative interventions. 1 
Drs Varelmann and
Muehlschlegel did an excellent job reviewing several studies with a specific focus on articles that likely will make an immediate clinical impact on care in cardiac surgical patients. More specifically in their review they focused on topics such as transfusion medicine, antiarrhythmic therapy, mechanical circulatory support devices, patient-oriented outcome data on transcatheter valve replacement, and a new inotropic medication-levosimendan. Similarly, our second review by Dr Ivascu and colleagues also focused on reviewing levosimendan, a calcium sensitizer that opens ATP-dependent potassium channels, that can be used as an alternative and/or a rescue inodilator for acute heart failure. 2 Additional topics reviewed by Dr Ivascu and colleagues with direct relevance to anesthesiologists practicing critical care medicine include vasopressor support, timing of renal replacement therapy, management of postoperative respiratory failure and targeted temperature therapy. Our journal strives to present information in a truly multidisciplinary approach, and so the section on adult cardiac surgical care would not be complete without representation from our cardiothoracic surgical colleagues. Drs Reece and Cleveland have focused on areas of emerging technologies in the cardiothoracic surgical field, 3 including topics on interventional valve procedures such as mitral valve repair, as well as aortic valve repairs and replacements. The second major surgical area covered in their review is on advances in aortic arch surgery and the review of literature specifically focusing on advancing repair options in aortic dissection.
One challenging task for our expert contributors writing articles on summarizing the Noteworthy Literature is to provide an all-inclusive and relevant overview of the literature to the readers of our journal. Nevertheless, some studies with substantial impact on perioperative care of cardiac surgical patients may not get included due to their timing of publication and our journal's publication deadlines. There has been one additional article that went to press in late November that deserves to be reviewed and discussed in our editorial. Blood transfusion, coagulation management, and the impact on patients has been debated for a very long time. Contemporary literature is abundant with seminal articles examining blood transfusion practices and the impact of blood transfusion on patient outcomes after cardiac surgery. In 1999, Hebert and colleagues published their study on liberal versus restrictive transfusion strategies in 838 critically ill patients who were randomized to maintenance hemoglobin levels of 7 to 9 g/dL or 10 to 12 g/dL and demonstrated that a restrictive approach was noninferior and possibly superior to a liberal strategy. 4 However, they observed that patients with significant cardiac comorbidities, contrary to the other critically ill patients in the study, were more likely to benefit from a more liberal transfusion approach. Since the publication of this study, several investigators have conducted trials looking to determine the potential risk associated with blood transfusion in patients with significant cardiac disease, and in particular of patients undergoing cardiac surgery. [5] [6] [7] [8] In 2015, Murphy et al 9 published the results of their study titled Transfusion Indication Threshold Reduction (TITRe2) trial in which 2007 patients were studied and demonstrated an increase in mortality at 90 days for cardiac surgical patients who were treated according to a restrictive transfusion protocol. Nevertheless, there were some major criticisms raised over how the study was designed and conducted including concerns that randomization in the study did not occur until after surgery, and thus patients were not randomized for intraoperative blood transfusion management.
To address some of the major limitations of the previously conducted studies, Dr Mazer and colleagues 10 designed and conducted their Transfusion Requirements in Cardiac Surgery (TRICS) III trial. The TRICS III trial was a large-scale, randomized controlled noninferiority trial looking at the effect of liberal versus restrictive transfusion strategies in patients undergoing cardiac surgery with cardiopulmonary bypass. 10 A total of 5243 patients in this large, international, multicenter study were randomized to receive red blood cell transfusion at a hemoglobin threshold of 7.5 g/dL (restrictive group) or at a hemoglobin threshold of 9.5 g/dL (liberal group). Randomization of study patients occurred prior to surgery, and the study protocol was reinforced throughout the hospital stay. The primary composite outcome defined by the authors was death from any cause, myocardial infarction, stroke, or newonset renal failure requiring dialysis at hospital discharge or at day 28, whichever came first. Secondary outcomes included red blood cell transfusion and other clinical outcomes. The authors were able to demonstrate the same pattern seen in some of the other patient populations that have previously been studied, namely that using a restrictive transfusion threshold of hemoglobin level of 7.5 g/dL for triggering red blood cell transfusion was noninferior to a liberal strategy (threshold of 9.5 g/dl) in the cardiac surgical patient population. The main difference noted between the 2 treatment groups was the number of units of red blood cells transfused. The primary composite outcome was not different between the 2 groups, leading the authors to conclude that similar results can be obtained in moderate-to high-risk patients having cardiac surgery, while following a more restrictive transfusion strategy.
The extent and depth of literature reviewed by the 2017 Noteworthy series is quite impressive. Along with the articles mentioned, we have a series of subspecialty articles that all have relevance to a broad audience. New to the collection of the journal's noteworthy collection this year is a focused review on echocardiographic imaging. Dr Goeddel and colleagues 11 in their review focused on describing studies on 3-dimensional echocardiography and the impact this modality has had on valve repair; the impact echocardiography has had on interventional procedures and minimally invasive procedures; new echocardiography techniques that are relevant for research purposes; and the use and utility of echocardiography in the intensive care unit setting.
In the second year since partnering with the Society for Advancement of Transplant Anesthesia, the Noteworthy series has paired articles covering both thoracic and abdominal transplantation. Drs Del Rio, Maerz, and Subramaniam have reviewed studies from the field of cardiothoracic transplantation. Overall themes covered in this extensive review include preoperative donor and recipient risk factor management strategies such as recipient risk factor identification, modification of those risk factors, optimization of recipient condition before transplantation, exploration of improved organ protective strategies and concepts relevant to perioperative management of these patients. 12 Under each of these themes, there are a number of interesting and timely articles covered. More specifically, the authors provided a specific summary on the management of pulmonary hypertension, using extracorporeal membrane oxygenation support as well as extravascular perfusion for patients with end-stage lung disease waiting for lung transplantation. Similarly, there is also a relevant summary of topics focusing on the management of heart transplant recipients with mechanical circulatory support and outcome of these patients. This review is followed by a transplant anesthesia review by Drs Zerillo, Smith, and Sakai with a focus on literature relevant to abdominal organ transplantation. 13 The authors searched through several thousands of potentially relevant publications to identify a selection of highly relevant topics such as a risk assessment and outcome prediction of perioperative complications, recommendations on perioperative management, economic analyses, and education of the trainees in abdominal transplantation anesthesia and critical care medicine. The combination of these 2 articles provides a highly relevant summary for anesthesiologists and trainees involved in the perioperative care of these patients.
Our journal has a continued commitment to multiple subspecialty areas relevant to the practice of pediatric cardiac anesthesia, as such we routinely publish articles geared toward our Congenital Cardiac subspecialty readers. Drs Ing and Twite have provided an annual review of the congenital literature since the inception of this Noteworthy series, and the 2017 version again provides a comprehensive review of highly relevant key topics such as anesthetic agent neurotoxicity and neurological outcomes, imaging in congenital heart disease, congenital cardiac registries, transfusion management as a well as bleeding versus thrombosis management, and adult congenital heart disease.
14 The congenital review, much like our Noteworthy transplant reviews, cover some very specialized topics; however, there is also a significant number of topics pertinent to a broader audience, especially the sections on management of adult patients with congenital heart disease.
In this issue of the journal under the Congenital Cardiac Forum section the article by Drs Subat and colleagues 15 comprehensively summarizes the utility of simulation in the management of patients with congenital heart disease. Their article highlights the complexity of congenital heart disease while describing the role of simulation in the education of residents, nurses, and students to better prepare these care providers for the management of patients with congenital heart disease. They also review specific simulation methods, and how relevant and helpful these methods could be to a variety of care providers whose experience with patients with congenital heart disease is crucial to the care of these patients.
The March issue is concluded by a series of case reports that could be of high of interest to practicing cardiac anesthesiologists. Dr Smeltz and colleagues 16 report on a case report of a BioGlue-associated loss of aortic valve leaflet motility that was particularly difficult to detect since sonographically this loss of motility of the leaflets was masked by both newly replaced mechanical aortic and mitral valves. This case report elegantly highlights that while BioGlue use has been shown to be an ideal method to reinforce cardiac surgical repairs, and thus reduce the risk for anastomotic bleeding, lower pledglet use, and lower overall short-term neurological events, its use is not without certain unexpected complications as the described case report demonstrated. Furthermore, when such complications occur, their detection by intraoperative transesophageal echocardiography might be hindered, and thus, reliance on other modalities of diagnosis should be considered.
Malignant hyperthermia is a rare but feared lifethreatening skeletal muscle disorder, which can be triggered by multiple agents during general anesthesia. The use of cardiopulmonary bypass and temperature management during cardiac surgery can obscure many of the characteristic signs and symptoms of malignant hypothermia, and hence, delay a prompt diagnosis. The case report presented by Drs Sams and colleagues 17 of a patient who developed malignant hypothermia after cardiac surgery with cardiopulmonary bypass provides a unique example of the delayed initial presentation of malignant hyperthermia, and highlights the specific treatment considerations for malignant hypothermia in patients undergoing cardiac surgery.
Intravascular foreign bodies may be either iatrogenic, or traumatic, and embolization of them may result in severe complications requiring urgent surgical or percutaneous interventions. The current increasing use of endovascular interventions and devices highlight the likelihood that anesthesiologists will encounter a case(s) of intravascular foreign body embolization during their clinical careers. The case report described by Drs Herbert and Kertai 18 not only details a perioperative course of a patient who developed an intracardiac embolization of an inferior vena cava stent but also highlights the role of intraoperative transesophageal echocardiography in the diagnosis, clinical decision making, and management.
In summary, we the editors-in-chief are truly excited to bring this March issue to the attention of our readers, which through its compilation of Noteworthy articles, a congenital forum and case reports of clinically challenging cases truly demonstrate the exciting changes that have recently occurred in cardiothoracic and abdominal transplant anesthesiology and surgery.
